(CABA) Cabaletta Bio - Performance -79.1% in 12m
CABA performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-70.21%
#102 in Peer-Group
Rel. Strength
3.25%
#7435 in Stock-Universe
Total Return 12m
-79.13%
#173 in Peer-Group
Total Return 5y
-87.69%
#106 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 7.86 USD |
| 52 Week Low | 1.04 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 60.03 |
| Buy/Sell Signal +-5 | -1.40 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: CABA (-79.1%) vs XBI (-14%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
-1.6% | 59% | 71.9% | 24.1 | 14.3 | 0.24 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
1.62% | -10.4% | 150% | 12 | 11 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
-1.03% | -8.54% | 32.3% | 27.4 | 14.2 | 0.99 | 0.60% | 41% |
| NBIX NASDAQ Neurocrine Biosciences |
4.99% | -11% | 0.55% | 45.7 | 26.2 | 0.27 | 18.7% | -34.3% |
| BIM PA Biomerieux |
-2.07% | 25.1% | -6.95% | 32.7 | 25.8 | 1.55 | -38.5% | -25.1% |
| KMDA NASDAQ Kamada |
5.73% | 34.5% | -14.4% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-7.94% | 44.1% | -14.3% | 7.54 | 6.09 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
-1.57% | 27.9% | 14.5% | 28.8 | 15.2 | 0.63 | -62.1% | -19.3% |
Performance Comparison: CABA vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for CABA
| Total Return (including Dividends) | CABA | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -15.76% | 3.06% | 3.54% |
| 3 Months | 45.54% | 12.25% | 16.07% |
| 12 Months | -79.13% | -13.98% | 12.18% |
| 5 Years | -87.69% | -27.36% | 107.69% |
| Trend Score (consistency of price movement) | CABA | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -61.4% | 76.5% | 91.9% |
| 3 Months | 51.1% | 79.3% | 97.5% |
| 12 Months | -90% | -87.3% | 47% |
| 5 Years | -20.9% | -51.7% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th7.50 | -18.26% | -18.64% |
| 3 Month | %th77.50 | 29.65% | 25.39% |
| 12 Month | %th14.00 | -75.74% | -81.39% |
| 5 Years | %th47.00 | -83.05% | -94.07% |
FAQs
Does Cabaletta Bio (CABA) outperform the market?
No,
over the last 12 months CABA made -79.13%, while its related Sector, the SPDR S&P Biotech (XBI) made -13.98%.
Over the last 3 months CABA made 45.54%, while XBI made 12.25%.
Performance Comparison CABA vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
CABA vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 7.7% | -19.3% | -32.2% | -91% |
| US NASDAQ 100 | QQQ | 7.2% | -20.1% | -34.6% | -92% |
| German DAX 40 | DAX | 8.6% | -17.3% | -42.9% | -108% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 7.1% | -20.7% | -36.2% | -99% |
| Hongkong Hang Seng | HSI | 7.1% | -18.2% | -54.2% | -113% |
| India NIFTY 50 | INDA | 9.4% | -16.3% | -33.6% | -76% |
| Brasil Bovespa | EWZ | 12.3% | -12.8% | -44.3% | -80% |
CABA vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 8.7% | -17.6% | -36.3% | -103% |
| Consumer Discretionary | XLY | 7.3% | -18.3% | -23.4% | -95% |
| Consumer Staples | XLP | 9.5% | -15% | -32.9% | -86% |
| Energy | XLE | 9.8% | -15.5% | -21.9% | -77% |
| Financial | XLF | 9% | -18.3% | -31.7% | -101% |
| Health Care | XLV | 9.7% | -13.9% | -21.7% | -70% |
| Industrial | XLI | 7.3% | -20.4% | -38% | -101% |
| Materials | XLB | 10.2% | -17.4% | -30% | -80% |
| Real Estate | XLRE | 8.2% | -15.2% | -31% | -85% |
| Technology | XLK | 7.3% | -22.1% | -38% | -90% |
| Utilities | XLU | 6.9% | -17.7% | -34.9% | -101% |
| Aerospace & Defense | XAR | 4.8% | -25% | -52.7% | -128% |
| Biotech | XBI | 6.5% | -18.8% | -23.6% | -65% |
| Homebuilder | XHB | 9.3% | -21.3% | -18.8% | -72% |
| Retail | XRT | 8.9% | -18.6% | -28% | -84% |
CABA vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 10.2% | -11.5% | -15.8% | -73% |
| Natural Gas | UNG | 3.2% | -7.3% | -7.9% | -86% |
| Gold | GLD | 7.1% | -14.1% | -49.8% | -116% |
| Silver | SLV | 5% | -19.5% | -49.1% | -101% |
| Copper | CPER | 6.4% | -29.4% | -50.9% | -102% |
CABA vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 9.1% | -15.6% | -26.7% | -75% |
| iShares High Yield Corp. Bond | HYG | 8.1% | -16.7% | -30.2% | -88% |